New Zealand markets closed

Integrated Diagnostics Holdings plc (IDHC.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.3250+0.0040 (+1.25%)
At close: 04:35PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 195.00M
Enterprise value 201.44M
Trailing P/E 12.31
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.13
Price/book (mrq)3.47
Enterprise value/revenue 2.20
Enterprise value/EBITDA 6.08

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-27.78%
S&P500 52-week change 323.76%
52-week high 30.6280
52-week low 30.2900
50-day moving average 30.3305
200-day moving average 30.3601

Share statistics

Avg vol (3-month) 3468.95k
Avg vol (10-day) 3186.4k
Shares outstanding 5600M
Implied shares outstanding 6601.87M
Float 8276.8M
% held by insiders 132.91%
% held by institutions 140.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 416 Jun 2022
Last split factor 24:1
Last split date 324 Dec 2020

Financial highlights

Currency in EGP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 17.25%
Operating margin (ttm)18.81%

Management effectiveness

Return on assets (ttm)8.90%
Return on equity (ttm)22.44%

Income statement

Revenue (ttm)4.38B
Revenue per share (ttm)7.30
Quarterly revenue growth (yoy)27.90%
Gross profit (ttm)N/A
EBITDA 1.12B
Net income avi to common (ttm)754.98M
Diluted EPS (ttm)0.0300
Quarterly earnings growth (yoy)141.50%

Balance sheet

Total cash (mrq)983.55M
Total cash per share (mrq)1.64
Total debt (mrq)1.29B
Total debt/equity (mrq)37.83%
Current ratio (mrq)1.51
Book value per share (mrq)0.76

Cash flow statement

Operating cash flow (ttm)558.66M
Levered free cash flow (ttm)253.81M